Compendium of Cancer Genome Aberrations

HAEM5:EBV-positive diffuse large B-cell lymphoma: Difference between revisions

(View all pending changes)
[pending revision][pending revision]
← Older editNewer edit →
VisualWikitext
Line 137: Line 137:
|
|
|-
|-
|''CCR6''<ref name=":2" />
|
|
|
|
|
|
|Mutations in '''CCR6''' may act as oncogenic drivers—especially in MALT lymphoma—by disrupting β-arrestin–mediated receptor desensitization, leading to unchecked intracellular signaling.
|-
|''CCR7''<ref name=":2" />
|
|
|
|
|
|
|-
|''DAPK1''<ref name=":2" />
|
|
|
|
|
|
|-
|''TNFRSF21''<ref name=":2" />
|
|
|
|
|
|
|-
|''CSNK2B''<ref name=":2" />
|
|
|
|
|
|
|-
|''YY1''<ref name=":2" />
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/HAEM5:EBV-positive_diffuse_large_B-cell_lymphoma"